Crescita Therapeutics (TSE:CTX) Trading Up 2% – Here’s What Happened

Crescita Therapeutics Inc. (TSE:CTX) traded up 2% during mid-day trading on Tuesday . The stock traded as high as C$0.52 and last traded at C$0.52. 36,623 shares traded hands during trading, a decline of 9% from the average session volume of 40,141 shares. The stock had previously closed at C$0.51.

Crescita Therapeutics Trading Up 2.0%

The stock has a market capitalization of C$9.68 million, a P/E ratio of 26.00 and a beta of 0.00. The firm’s 50 day simple moving average is C$0.47 and its two-hundred day simple moving average is C$0.47. The company has a quick ratio of 2.29, a current ratio of 2.70 and a debt-to-equity ratio of 5.77.

Crescita Therapeutics (TSE:CTX) last issued its earnings results on Wednesday, November 5th. The company reported C$0.04 EPS for the quarter. Crescita Therapeutics had a negative return on equity of 15.60% and a negative net margin of 15.73%.The business had revenue of C$5.39 million during the quarter.

About Crescita Therapeutics

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.